# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001048477-25-000047
Filing Date
2025-04-08
Accepted
2025-04-08 16:12:10
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | a2025biomarinna.htm | DEFA14A | 9975
2 |  | logo_biomarina.jpg | GRAPHIC | 98989
3 |  | na_1a.jpg | GRAPHIC | 753923
4 |  | na_2a.jpg | GRAPHIC | 677626
| Complete submission text file | 0001048477-25-000047.txt |  | 2118179

Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26727 | Film No.: 25822075
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)